Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma

Sphingolipid (SL) metabolism alterations have been frequently reported in cancer including in melanoma, a bad-prognosis skin cancer. In normal cells, de novo synthesized ceramide is mainly converted to sphingomyelin (SM), the most abundant SL, by sphingomyelin synthase 1 (SMS1) and, albeit to a less...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Bilal, Fatima, Montfort, Anne, Gilhodes, Julia, Garcia, Virginie, Riond, Joëlle, Carpentier, Stéphane, Filleron, Thomas, Colacios, Céline, Levade, Thierry, Daher, Ahmad, Meyer, Nicolas, Andrieu-Abadie, Nathalie, Ségui, Bruno
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2019
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503817/
https://ncbi.nlm.nih.gov/pubmed/31114500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00443
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller